The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management

Sponsor
University Medical Center Groningen (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06110624
Collaborator
(none)
20
2
5
10
2

Study Details

Study Description

Brief Summary

A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory.

Condition or Disease Intervention/Treatment Phase
  • Other: Survey

Detailed Description

A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt- PC in daily practice. GHCPs are recruited via the connections of the seven Centers of Expertise in Palliative Care. To invite them to participate in the study, the GHCPs are approached directly via e-mail or telephone. Participating GHCPs will be educated on how to use MuSt-PC (educational materials and instruction webinar). GHCPs will be asked to use the CDSS for five individual patients. Every time after using MuSt-PC they will be asked to answer additional questions about their experience with using MuSt-PC in that specific instance. After using MuSt-PC for five patients, they are requested to fill out a comprehensive questionnaire about their overall experiences with using the CDSS.

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The MuSt-PC: A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs - Feasibility Study
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Arm 1

A targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population.

Other: Survey
A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt-PC in daily practice.

Outcome Measures

Primary Outcome Measures

  1. Questions evaluating Intention to Use (IU) [after 5 times use of the MuSt-PC tool within 3 months]

    Questions evaluating Intention to Use (IU) (7-point Likert scales)

Secondary Outcome Measures

  1. Questions evaluating other modified TAM domains [after 5 times use of the MuSt-PC tool within 3 months]

    Questions evaluating other modified TAM domains: Perceived Usefulness, Perceived Ease-of-Use, Attitude, Compatibility, Subjective norm, Facilitators, Habit (7-point Likert Scales).

  2. Perceived benefits and disadvantages of using MuSt-PC [after 5 times use within 3 months]

    Perceived benefits and disadvantages of using MuSt-PC (open-ended questions).

  3. Suggestions to improve the MuSt-PC CDSS [after 5 times of the MuSt-PC tool within 3 months]

    Suggestions to improve the MuSt-PC CDSS (open-ended question).

  4. An overview of the content of questions of participating GHCPs regarding MuSt-PC use. [after 5 times use within 3 months]

    An overview of the content of questions of participating GHCPs regarding MuSt-PC use. Questions will be analyzed qualitatively; coding will be done independently by two researchers. In case of disagreement, consensus will be achieved through discussion. Coding will result in categorization of question subject. Categorizations are ranked from most prevalent to least prevalent question subject (proportion of respondents).

  5. Most useful elements of MuSt-PC will be evaluated with a multiple-choice question. [after 5 times use within 3 months]

    Most useful elements of MuSt-PC will be evaluated with a multiple-choice question. (multiple answers allowed) Frequency and percentage of total respondents who chose the multiple choice answer possibilities will be evaluated

  6. Mean scores of HCPs adherence to CDSS recommendations [after 5 times use of the MuSt-PC tool within 3 months]

    Mean scores (5-point Likert scale) of HCPs adherence to CDSS recommendations (each time using MuSt-PC)

Other Outcome Measures

  1. A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use [after 5 times use of the MuSt-PC tool within 3 months]

    A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use: Insufficient IU is defined as a sum score of ≤12 for the 3 questions that measure Intention to Use by the modified TAM questionnaire (maximum sum score 21) Insufficient PU is defined as a sum score of ≤24 for the 6 questions that measure PU by the modified TAM questionnaire (maximum sum score 42) insufficient PEU is defined as a sum score of ≤24 for the 6 items that measure PEU by the modified TAM questionnaire (maximum sum score 42). (see Appendix G) Six to twelve GHCPs with a sum score of ≤12 (IU) and/or ≤24 (PU and/or PEU) will be invited to participate.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate:

  • General practice

  • Nursing home

  • Hospital:

  • Clinical geriatrics

  • Medical oncology

  • Radiation oncology

  • Pulmonology

  • Cardiology

Exclusion Criteria:

HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation.

GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Medical Center Groningen Groningen Netherlands
2 LUMC Leiden Netherlands

Sponsors and Collaborators

  • University Medical Center Groningen

Investigators

  • Principal Investigator: An KL Reyners, MD, PhD, University Medical Center Groningen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anna KL Reyners, Prof., University Medical Center Groningen
ClinicalTrials.gov Identifier:
NCT06110624
Other Study ID Numbers:
  • 11265
First Posted:
Oct 31, 2023
Last Update Posted:
Oct 31, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 31, 2023